References

1. 1.
   ZOCCALI C.Traditional and emerging cardiovascular and renal risk factors：An epidemiologic perspective［J］.Kidney Int，2006，70（1）：26-33.
2. 2.
   Global，regional，and national burden of chronic kidney disease，1990-2017：A systematic analysis for the Global Burden of Disease Study 2017［J］.Lancet，2020，395 （10225）：709-733.
3. 3.
   NOELS H，LEHRKE M，VANHOLDER R，et al. Lipoproteins and fatty acids in chronic kidney disease：Molecular and metabolic alterations［J］.Nat Rev Nephrol，2021，17 （8）：528-542.
4. 4.
   MIZUSHIMA N，LEVINE B，CUERVO A M，et al. Autophagy fights disease through cellular self-digestion［J］.Nature，2008，451 （7182）：1069-1075.
5. 5.
   TANG C，LIVINGSTON M J，LIU Z，et al. Autophagy in kidney homeostasis and disease［J］.Nat Rev Nephrol，2020，16 （9）：489-508.
6. 6.
   ZHANG L Q， ZHU J G， WANG Q， et al. Impact of Yishen Huayu prescription on the expressions of matrix metalloproteinase-1 and its inhibitor in renal tissue of renal interstitial fibrosis rats［J］.J Tradit Chin Med， 2016，57（15）：1332-1336.
7. 7.
   LI L， ZHANG L Q.Study on the mechanism of Yishen Huayu prescription against renal interstitial fibrosis based on the transdifferentiation of HK-2 cells［J］. China J Tradit Chin Med Pharm， 2022，37 （2）： 1149-1153.
8. 8.
   JUNG K T，OH S H. The role of autophagy in cadmium-induced acute toxicity in glomerular mesangial cells and tracking polyubiquitination of cytoplasmic p53 as a biomarker［J］.Exp Mol Med，2022，54 （5）：685-696.
9. 9.
   WU Q，HU Y，JIANG M，et al. Effect of autophagy regulated by Sirt1/FoxO1 pathway on the release of factors promoting thrombosis from vascular endothelial cells［J］.Int J Mol Sci，2019，20 （17）：4132.
10. 10.
    XU S Y， BIAN R L， CHEN X. Methodology of pharmacological experiment［M］. Beijing： People's Medical Publishing House， 2002：1937.
11. 11.
    CAO Y，HU J，SUI J，et al. Quercetin is able to alleviate TGF-β-induced fibrosis in renal tubular epithelial cells by suppressing miR-21［J］.Exp Ther Med，2018，16 （3）：2442-2448.
12. 12.
    ZHANG X R， YU M， DONG J W， et al. Establishment of HPLC fingerprint of Cuscutae Semen in wine and analysis of composition differences of Cuscutae Semen before and after processing［J］.China J Tradit Chin Med Pharm， 2024，39（2）：718-723.
13. 13.
    GAO J M. Study on the antioxidative effect and mechanism of semen cuscuta aqueous extract［D］.Shenyang：Shenyang Pharmaceutical University， 2013.
14. 14.
    CHEN C， LI J. Effects of salvia miltiorrhiza and its active components on renal fibrosis［J］.Chin J Integr Tradit West Nephrol， 2020，21（12）：1119-1121.
15. 15.
    XIONG C X，HOU Q D，SHAO X F，et al.The study of mechanism of salvianolate anti-fibrosis and renoprotective effect on chronic kidney disease by inhibiting the activation of Wnt/β-catenin and TGF-β₁/Smad3 signaling pathway［J］.Chin J Integr Tradit West Nephrol，2023，24（7）：577-581，660.
16. 16.
    HUANG Y F，XU C G，WEI G Y.Research progress on Curcuma kwangsiensis［J］.Guizhou Agri Sci，2020，48（8）：104-110.
17. 17.
    LIU Z H， CHENG J G. Effects of Zedoary turmeric on the expression of TGF-β₁， α-SMA and ColⅠ in rats with unilateral ureteral obstruction［J］. Zhejiang J Tradit Chin Med，2012，47（9）：669-670.
18. 18.
    CUI X L， LIU X J. Effects of breviscapine injection on expressions of VEGF in kindey of diabetic rats［J］. Pharmacol Clin Chin Mater Med，2016，32（1）：145-149.
19. 19.
    GUO J F ，WANG X M ，ZHANG Q E，et al. Research progress on traditional Chinese medicine interventions targeting NF-κB signaling pathway to improve diabetic nephropathy［J］. Chin J Exp Tradit Med Form，2024，30（20）：241-251.
20. 20.
    LI Y T， WANG L Q， LIU D W， et al. Rhein Ameliorates fibrosis of HK-2 human renal tubular epithelial cells by activating the Nrf2/HO-1 signaling pathway［J］. Pharmacol Clin Chin Mater Med，2023，39（11）：52-57.
21. 21.
    FU E L，CLASE C M，EVANS M，et al. Comparative effectiveness of renin-angiotensin system inhibitors and calcium channel blockers in individuals with advanced CKD： A nationwide observational cohort study［J］.Am J Kidney Dis，2021，77 （5）：719-729.
22. 22.
    MA T T，MENG X M.TGF-β/Smad and renal fibrosis［J］.Adv Exp Med Biol，2019，1165： 347-364.
23. 23.
    WANG Y J，CHEN Y Y，HSIAO C M，et al.Induction ofautophagy by pterostilbene contributes to the prevention of renal fibrosis via attenuating NLRP3 inflammasome activation and epithelial-mesenchymal transition［J］.Front Cell Dev Biol，2020，8：436.
24. 24.
    GUAN Y，HAO C M. SIRT1 and kidney function［J］.Kidney Dis （Basel），2016，1（4）：258-265.
25. 25.
    QIAO L，SHAO J. SIRT1 regulates adiponectin gene expression through Foxo1-C/enhancer-binding protein alpha transcriptional complex［J］.J Biol Chem，2006，281 （52）：39915-39924.
26. 26.
    JI L，WANG Q，HUANG F，et al.FoxO1 overexpression attenuates tubulointerstitial fibrosis and apoptosis in diabetic kidneys by ameliorating oxidative injury via TXNIP-TRX［J］.Oxid Med Cell Longev，2019，doi：.
27. 27.
    WANG Z，GUO WD，YI F，et al.The regulatory effect of SIRT1 on extracellular microenvironment remodeling［J］.Int J Biol Sci，2021，17（1）： 89-96.
28. 28.
    YI J，LUO J.SIRT1 and p53，effect on cancer，senescence and beyond［J］.Biochim Biophys Acta，2010，1804（8）：1684-1689.
29. 29.
    LINK W，FERNANDEZ-MARCOS P J. FoxO transcription factors at the interface of metabolism and cancer［J］.Int J Cancer，2017，141 （12）：2379-2391.
30. 30.
    YANG M，WANG J J，ZHUANG X F，et al.Mechanism of in vitro and in vivo models of osteoporosis regulation by active ingredients of traditional Chinese medicine：A review［J］.Chin J Exp Tradit Med Form，2025，31（3）：281-289.